Previous 10 | Next 10 |
SAN DIEGO, Feb. 25, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication in Science of a study by the Human Genome Structural Variation Consortium (HGSVC) that used a combination of advanced sequencing and optical genome mapping (OGM) with Saphyr to a...
Illumina and its short reading technology pushed the sequencing costs down during the last decade. Long reads and artificial intelligence are improving the sequencing and will likely keep driving the costs lower. Several companies are building business models around these technolo...
Looking For The Best Health Care Stocks To Watch Right Now? 4 Names To Know You can’t deny that health care is a vital industry in the world we live in today. Similarly, health care stocks have and will likely continue to fill the same role in the stock market. With all e...
SAN DIEGO, Feb. 22, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced the publication of a study by its Lineagen team that describes the first genome-wide model to assess and score nearly all protein-coding genes based on their likelihood to cause central nervous syst...
Bionano Genomics (NASDAQ: BNGO) has certainly created a buzz in 2021. It's one of the top 100 most-popular stocks on Robinhood. Bionano's shares have skyrocketed more than 340% so far this year. With such a massive gain in such a short period, it's natural for investors to wonde...
We propose a method for selling options that defies many myths around options selling. We analyzed options prices using statistical modelling and calculus to improve the "expected value" of trading versus conventional principles. Trades based on the criteria below are likely to wi...
Even if you've never had to analyze a genome yourself, you'll probably agree that they're quite complicated. But what would you do if you did need to analyze a genome to diagnose a patient or solve a key scientific question in the course of research? If you don't have an answer to this ...
Shares of Bionano Genomics (BNGO) have hit an all-time high this afternoon, breaking the $14 barrier for the first time.In the past 30 days, shares have more than doubled, up 106%.Today alone, shares are up 22.8% to $14.37 in afternoon trading.An article published in InvestorPl...
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that company management will present virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference. Erik Holmlin, PhD, Bionano’s Chief Executive Officer,...
SAN DIEGO, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO), announced the publication of a method for using optical genome mapping (OGM) to identify structural variants (SVs) that drive cancer in a wide variety of solid tumor samples. The study, led by Dr. James Broa...
News, Short Squeeze, Breakout and More Instantly...
Bionano Genomics Inc. Company Name:
BNGO Stock Symbol:
NASDAQ Market:
Bionano Genomics Inc. Website:
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- A sponsored exhibitor session will feature Dr. Phillip Michaels from Harvard Medical School and Brigham and Women’s Hospital presenting data from a multi-site study evaluating the performance and benefits of optical genome mapping (O...
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that Erik Holmlin, PhD, Bionano’s president and chief executive officer, will present at the Canaccord Genuity 44 th Annual Growth Conference on August 13, 2024. Conference & ...
SAN DIEGO, July 31, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference call and live webcast on Wednesday, August 7, 2024, at 4:30 p.m. Eastern Time to report financial results for the second quarter 2024 and to highlight r...